I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of Study

Infectious Diseases

Cancer

Genetic Predisposition

Identity/Forensics

Other Diagnostic Applications

I. EXECUTIVE SUMMARY

1.MARKET DYNAMICS

What are DNA-Probes?

DNA-based Diagnostics – A Prelude

DNA Tests: Finding Use in Numerous Applications

DNA Probes: Robust Growth Ahead

Developed Markets: Traditional Revenue Contributors

The United States: Unraveling the Country’s Edge in DNA-based Diagnostics

Infectious Diseases Tests Dominate the DNA-based Diagnostics Market

Developing Countries Excel in Growth Prospects

Decoding the Genetic Puzzle

Advantages of DNA-Probe Tests

Growth Drivers in a Nutshell

Growth Inhibitors in a Nutshell

Genetic Profiling of Pathogens: A Road Less Traveled

Roche’s Entry into the Hall of Molecular Fame

DNA Technology: An Evolutionary Scan

Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005

Market Opportunities

2.MARKET DRIVERS AND TRENDS

World’s Aging Population Drives the Popularity of DNA-Probe Tests

Global Aging Population Statistics – Opportunity Indicators

Table 1: Global Population of 65+ Individuals in ?000s by Region for the Years 2015, 2020 & 2025 (includes corresponding Graph/Chart)

Table 2: Global Population Statistics for the 65+ Age Group in Select Countries (2017) (includes corresponding Graph/Chart)

Table 3: Life Expectancy at Birth (in Years) by Region for 2010-2015, 2020-2025 & 2045-2050 (includes corresponding Graph/Chart)

Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics

Table 4: Worldwide Cancer Prevalence (2017): Percentage Prevalence of Diagnosed Cancer Conditions in Adult Population in Select Countries (includes corresponding Graph/Chart)

Table 5: Global Cancer Incidence (2015): Number of New Cancer Cases in Thousands by Type and Gender (includes corresponding Graph/Chart)

Table 6: Global Cancer Mortality (2015): Number of Cancer Related Deaths in Thousands by Type and Gender (includes corresponding Graph/Chart)

Table 7: Worldwide Diabetes Prevalence (2017 & 2045): Percentage Prevalence of Diabetes in Adult Population (20-79 Years) by Geographic Region (includes corresponding Graph/Chart)

Table 8: Leading Countries with Diabetes Population (20-79 Years) in Million for the Years 2017 and 2045 (includes corresponding Graph/Chart)

AIDS: A Global Epidemic

Facts & Figures

Table 9: HIV Infection Statistics Worldwide by Geographic Region: As of 2016 (includes corresponding Graph/Chart)

Table 10: HIV Infection Statistics Worldwide for Adults, Women and Children: As of 2016 (includes corresponding Graph/Chart)

Table 11: Worldwide AIDS Related Deaths by Geographic Region: 2016 (includes corresponding Graph/Chart)

Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth

Table 12: Healthcare Spending as a Percentage of GDP in Select Countries (2016) (includes corresponding Graph/Chart)

Reimbursements: “Under the Umbrella”

Evolution of New & Virulent Infectious Agents

Challenges in Widespread Deployment of DNA-based Diagnostics

Improvements in Assay Capabilities

Information Handling & Processing: The Soft Side of Diagnostics

Integration: The Ultimate Challenge

DNA Probe Technology Gains Prominence in Diagnosing Vaginitis

Gene Banks – A Ray of Hope for the Future

3.DNA PROBES-BASED DIAGNOSTICS - A PRIMER

Diagnostic Gene Detection Products

Molecular Diagnostics: A Powerful Disease Detection Tool

DNA Probes-Based Products

Direct Detection of Target Sequence

Nucleic Acid Amplification

Gene Detection Using DNA Chips

Gene Detection by DNA Sequencing

The Dynamics of Key Enabling Technologies

Polymerase Chain Reaction (PCR)

In Situ Hybridization

Chemiluminescence

Gen-Probe Tigris

DNA Chips

Molecular Diagnostics – A Primer

Implications for Clinical Diagnostics

Need of the Hour

Impact of the Human Genome Project

“Tailored Patient Management”: An Epitomized Future of Molecular Diagnostics

Outlook

4.PRODUCT OVERVIEW

Background

Gene Probe Technology

What is DNA?

DNA Probes

Miniaturization: A Revolutionary Method in DNA Analysis

Gene Chip Technology

DNA Chips

Chromosome Painting Probes

Diagnostic Applications Based on DNA Probes: An Overview

Infectious Diseases

Respiratory Tract Infections

Diagnosis of Mycoplasma

DNA Probes to Detect Legionella Pneumophila

Detecting Tuberculosis through Rapid Diagnostic Tests

How the Technique Works

Limitations

Sexually Transmitted Diseases (STDs)

HIV

HTLV-1 Testing

Hepatitis Testing

Chlamydia DNA Probes

Detection of Intestinal Parasites

Entamoeba Histolytica

Salmonella

Malaria Testing

Identity/Forensics

DNA Profiling: A Key Forensic Tool

DNA-Based Forensic Diagnostics

Tracing Human Origins

Genetic Predisposition

Molecular HLA Testing

Human Leukocyte Antigen (HLA) Typing

Cancer Testing

Cancer: A Deadly Disease Afflicting Millions

Slow Detoxifiers: Potential Cancer Candidates

Improving Cancer Surgery through Diagnostic Tests

Types of Cancer

Chronic Lymphocytic Leukemia (CLL)

Breast Cancer

PCR Screening Technology for Breast Cancer

Eye Cancers

DNA Probes to Detect Retinoblastoma

Others

The Ames Test

Genetic Testing

Other Diagnostic Applications

Cystic Fibrosis

Duchenne’s Muscular Dystrophy

Huntington’s Disease

Diabetes

Detection of Multidrug Resistance

Bacterial Resistance to Antibiotics

6.RECENT INDUSTRY ACTIVITY

Thermo Fisher Scientific Acquires Affymetrix

Illumina Partners with Memorial Sloan Kettering

Cancer Genetics to Acquire BioServe Biotechnologies

7.FOCUS ON SELECT GLOBAL PLAYERS

Abbott Molecular (USA)

Beckman Coulter, Inc. (USA)

Becton, Dickinson and Company (USA)

bioM?rieux (France)

F. Hoffmann-La Roche Ltd. (Switzerland)

GE Healthcare Life Sciences (UK)

Luminex Corporation (USA)

QIAGEN N.V. (Netherlands)

Siemens Healthineers (Germany)

Thermo Fisher Scientific, Inc. (USA)

8.GLOBAL MARKET PERSPECTIVE

Table 13: World Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 14: World Historic Review for DNA Probes-based Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 15: World 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 16: World Recent Past, Current & Future Analysis for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 17: World Historic Review for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 18: World 14-Year Perspective for DNA Probes-based Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 19: World Recent Past, Current & Future Analysis for DNA Probes-based Cancer Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 20: World Historic Review for DNA Probes-based Cancer Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 21: World 14-Year Perspective for DNA Probes-based Cancer Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 22: World Recent Past, Current & Future Analysis for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 23: World Historic Review for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 24: World 14-Year Perspective for DNA Probes-based Genetic Predisposition Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 25: World Recent Past, Current & Future Analysis for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 26: World Historic Review for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 27: World 14-Year Perspective for DNA Probes-based Identity/Forensics Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 28: World Recent Past, Current & Future Analysis for DNA Probes-based Other Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 29: World Historic Review for DNA Probes-based Other Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 30: World 14-Year Perspective for DNA Probes-based Other Diagnostics by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

II. MARKET

1.THE UNITED STATES

A. Market Analysis

United States: The Largest Market for DNA-Probes Diagnostics

Key Challenges Facing the Market

Rise of DNA-Based Home Testing Kits Market

Ageing Demographics: A Major Driving Factor

Table 31: US Elderly Population by Age Group for Years 1990, 2000, 2010 and 2015 (includes corresponding Graph/Chart)

Diabetes Pandemic in the US: An Opportunity for DNA Probes-based Diagnostics

Table 32: Diabetes Statistics in the US (2017 & 2045) (includes corresponding Graph/Chart)

Table 33: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)

Growing Cancer Incidence – An Opportunity Indicator for DNA Probes-Based Diagnostics

Table 34: New Cancer Cases in the US by Gender and Affected Site: 2017 (includes corresponding Graph/Chart)

Table 35: Incidence of Four Major Cancers by Gender & Age Group in the US (2017): New Cancer Cases for Male & Female for the Age Groups Under 45 Years; 45 Years and Above; Under 65 Years; 65 Years and Above (includes corresponding Graph/Chart)

Table 36: The US Breast Cancer Incidence in Women by State (2017): New Cases of Breast Cancer in Leading 15 States (includes corresponding Graph/Chart)

Strategic Corporate Developments

Focus on Select Key Players

B. Market Analytics

Table 37: The US Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 38: The US Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 39: The US 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

2.CANADA

A. Market Analysis

Cancer Incidence in Canada: Opportunity Indicator

Table 40: New Cancer Cases in Canada (2017): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)

Table 41: New Cancer Cases in Canada by Province: 2017 (includes corresponding Graph/Chart)

Table 42: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)

Table 43: Cancer Related Deaths in Canada (2017): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart)

Diabetes Overview

Table 44: Diabetes Statistics in Canada (2017 & 2045) (includes corresponding Graph/Chart)

Table 45: Percentage Share Breakdown of Diabetic Population by Gender in Canada: 2016 (includes corresponding Graph/Chart)

Table 46: Percentage Share Breakdown of Diabetic Population by Age Group in Canada: 2016 (includes corresponding Graph/Chart)

B. Market Analytics

Table 47: Canadian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 48: Canadian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 49: Canadian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

3.JAPAN

A. Market Analysis

Graying Population Spurs Growth

Table 50: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)

Diabetes Statistics

Table 51: Diabetes Statistics in Japan (2017 & 2045) (includes corresponding Graph/Chart)

B. Market Analytics

Table 52: Japanese Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 53: Japanese Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 54: Japanese 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4.EUROPE

A. Market Analysis

Ageing Population Drives Demand

Table 55: European Country-wise Statistics of 65+ Population as % of Total Population: 2016 (includes corresponding Graph/Chart)

Cancer Incidence in Europe: An Opportunity Indicator for DNA Probes-Based Diagnostics

Table 56: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart)

A Glance at Key Diabetes Statistics in Europe

Table 57: Diabetes and Population Statistics in Europe (2017 & 2045) (includes corresponding Graph/Chart)

Table 58: Diabetes Statistics in Europe (2017) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ?000s) for Select Countries (includes corresponding Graph/Chart)

B. Market Analytics

Table 59: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 60: European Historic Review for DNA Probes-based Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 61: European 14-Year Perspective for DNA Probes-based Diagnostics by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

Table 62: European Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 63: European Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 64: European 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4a.FRANCE

A. Market Analysis

bioM?rieux – A Major French Player

B. Market Analytics

Table 65: French Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 66: French Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 67: French 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4b.GERMANY

A. Market Analysis

Siemens Healthineers – A Key German Player

B. Market Analytics

Table 68: German Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 69: German Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 70: German 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4c.ITALY

Market Analysis

Table 71: Italian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 72: Italian Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 73: Italian 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4d.THE UNITED KINGDOM

A. Market Analysis

GE Healthcare Life Sciences – A Leading UK Player

B. Market Analytics

Table 74: The UK Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 75: The UK Historic Review for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 76: The UK 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4e.SPAIN

Market Analysis

Table 77: Spanish Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 78: Spanish Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

Table 79: Spanish 14-Year Perspective for DNA Probes-based Diagnostics by Application Area - Percentage Breakdown of Revenues for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets for Years 2009, 2018 & 2022 (includes corresponding Graph/Chart)

4f.RUSSIA

Market Analysis

Table 80: Russian Recent Past, Current & Future Analysis for DNA Probes-based Diagnostics by Application Area - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)

Table 81: Russian Historic Review for DNA Probes-based Diagnostics by Application Area -Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, and Other Application Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)